降低运营成本
Search documents
气耗28公斤!李师傅“油转气”首选玉柴K14N
第一商用车网· 2025-09-16 06:58
Core Viewpoint - The article highlights the advantages of using gas heavy trucks, particularly the Dongfeng Tianlong KL equipped with the Yuchai K14N gas engine, as a cost-effective solution for transportation amidst rising fuel prices and competitive freight rates [1][3][15]. Group 1: Reasons for Choosing Gas Trucks - Rising fuel prices and intense competition in freight rates have made it difficult for truck drivers to maintain profitability with traditional fuel trucks [3][9]. - The gas heavy truck has become a preferred choice for reducing operational costs, especially for drivers with variable routes and high time-sensitive delivery requirements [5][11]. Group 2: Performance and Efficiency - The Yuchai K14N gas engine offers a maximum power of 540 horsepower and a torque of 2500 Nm, providing reliable performance even in challenging terrains [6][11]. - The average gas consumption of the truck is reported to be under 28 kg per 100 km, which is significantly lower than competitors, leading to substantial cost savings over long distances [7][9]. Group 3: Reliability and Comfort - The truck has shown high reliability with no reported faults over 130,000 km of operation, requiring only routine maintenance [11][13]. - The comfort level of the gas truck is comparable to that of a passenger car, enhancing the driving experience and allowing for effective communication while on the road [13][15]. Group 4: After-Sales Service - The after-sales service provided by Yuchai is highly regarded, with proactive maintenance checks ensuring the stability of core components [13][15]. - The trust in the Yuchai brand is evident, as drivers recommend it to peers considering switching to gas trucks [15].
海南发展控股子公司海控三鑫停窑减产
Zhi Tong Cai Jing· 2025-07-29 09:32
海南发展(002163)(002163.SZ)公告,公司控股子公司海控三鑫(蚌埠)新能源材料有限公司(简称"海控 三鑫")于近期对550吨窑炉及5条深加工生产线进行停窑减产。公告称,海控三鑫停窑减产,有利于降低 运营成本,减少公司经营亏损。 ...
泰晶科技: 泰晶科技股份有限公司关于全资子公司之间吸收合并的公告
Zheng Quan Zhi Xing· 2025-06-05 09:37
Overview of the Merger - The company has approved a merger between its wholly-owned subsidiaries, Chongqing Jinxin Frequency Control Electronics Co., Ltd. and Chongqing Taiqing Electronics Co., Ltd., to optimize resource allocation, reduce operational costs, and improve management efficiency [1][2][3] - After the merger, Chongqing Jinxin will continue to operate, while Chongqing Taiqing will be legally dissolved, with all debts and assets transferred to Chongqing Jinxin [1][3] Details of the Merging Entities - **Chongqing Jinxin Frequency Control Electronics Co., Ltd.**: Established on March 26, 2020, with a registered capital of 100 million yuan, it specializes in manufacturing electronic components and medical masks [1][2] - **Chongqing Taiqing Electronics Co., Ltd.**: Established on May 28, 2018, with a registered capital of 20 million yuan, it focuses on the research, production, and sales of quartz crystal frequency components. As of December 31, 2024, it reported total assets and a net loss of approximately 8 million yuan [2][3] Impact of the Merger - The merger is expected to enhance resource allocation, lower operational costs, and improve management efficiency, aligning with the company's development strategy [3] - The merger will not have a substantial impact on the company's normal operations and does not constitute a related party transaction or a major asset restructuring, ensuring the protection of all shareholders' interests, especially minority shareholders [3]
阳光诺和: 关于注销孙公司南京诺和欣医药科技有限公司暨关联交易的议案
Zheng Quan Zhi Xing· 2025-05-12 12:25
证券代码:688621 证券简称:阳光诺和 公告编号:2025-042 北京阳光诺和药物研究股份有限公司 关于注销孙公司南京诺和欣医药科技有限公司暨关 联交易的议案 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示: ? 北京阳光诺和药物研究股份有限公司(以下简称"公司"或"阳光诺 和")拟注销控股孙公司南京诺和欣医药科技有限公司(以下简称"诺和欣")。 ? 赵凌阳先生在 2019 年 1 月-2024 年 9 月期间历任阳光诺和董事会秘书、 董事、财务总监,且持有诺和欣 18%股权。本次拟注销控股孙公司事项构成关联 交易,不构成重大资产重组。 ? 根据《上海证券交易所科创板股票上市规则》的有关规定,过去 12 个月 内,公司与同一关联人发生的关联交易,累计金额未达到占公司最近一期经审计 总资产或市值 1%以上的交易,且超过 3000 万元,本次关联交易金额在董事会审 批权限之内,无需提交股东会审议。 公司于 2025 年 5 月 12 日召开第二届董事会第十九次会议,审议通过了《关 于注销孙公司南京诺和欣医药 ...